György M. Keserű

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

A. Douangamath, D. Fearon, Paul Gehrtz et al. · Nature Communications · 2020 · 527 citations · Full text

GPCRdb in 2021: integrating GPCR sequence, structure and function

Albert J. Kooistra, Stefan Mordalski, Gáspár Pándy‐Szekeres et al. · Nucleic Acids Research · 2020 · 366 citations · Full text

Drug Target, Engineering, Molecular Biology +19

Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia

György M. Keserű, Daniel A. Erlanson, György G. Ferenczy et al. · Journal of Medicinal Chemistry · 2016 · 225 citations

Pharmaceutical Research, Hit Identification, Molecular Biology +20

GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources

Gáspár Pándy‐Szekeres, Jimmy Caroli, Alibek Mamyrbekov et al. · Nucleic Acids Research · 2022 · 197 citations · Full text

Structural Bioinformatics, New Ligand Resources, Biomolecular Structure Prediction +22

Impact of Lipophilic Efficiency on Compound Quality

Ákos Tarcsay, Kinga Nyíri, György M. Keserű · Journal of Medicinal Chemistry · 2012 · 159 citations

Lipid Preparation, Balanced Optimization, Medicinal Chemistry +15